Table 2.
Relationship between nm23H1, VEGF-C, MLC, and clinicopathology of PCa tissue.
| Clinicopathological | No. of cases | nm23H1-positive cases (%) | VEGF-C-positive cases (%) | MLC /mm2 mean ± dev |
|---|---|---|---|---|
| adjacent benign tissues | 4.51 ± 2.64 | |||
| Pathologic grade | ||||
| I and II | 21 | 6 (28.27) | 9 (42.86) | 8.61 ± 2.67 |
| III and IV | 21 | 13 (61.91) | 10 (47.62) | 7.92 ± 2.04 |
| TNM stage | ||||
| I and II | 22 | 20 (90.91) | 7 (31.82) | 7.45 ± 2.91 |
| III and IV | 20 | 9 (45.00) ** | 12 (60.00) * | 9.79 ± 2.68 * |
| Lymph node metastasis | ||||
| Negative | 31 | 25 (80.65) | 8 (25.81) | 6.93 ± 1.80 |
| Positive | 11 | 4 (36.36) ** | 11 (100) ** | 11.16 ± 1.39 * |
* P < 0.05, ** P < 0.01.